Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism.

about

Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism.

Item

http://www.wikidata.org/entity/Q39443793

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Hepatitis C virus and proprote ...... and disrupt lipid metabolism.

@en

Hepatitis C virus and proprote ...... and disrupt lipid metabolism.

@nl

type

Item

label

Hepatitis C virus and proprote ...... and disrupt lipid metabolism.

@en

Hepatitis C virus and proprote ...... and disrupt lipid metabolism.

@nl

prefLabel

Hepatitis C virus and proprote ...... and disrupt lipid metabolism.

@en

Hepatitis C virus and proprote ...... and disrupt lipid metabolism.

@nl

P1476

Hepatitis C virus and proprote ...... and disrupt lipid metabolism.

@en

P2093

Daniela Francisci

http://www.w3.org/2001/XMLSchema#string

Elisabetta Schiaroli

http://www.w3.org/2001/XMLSchema#string

Francesco Bagaglia

http://www.w3.org/2001/XMLSchema#string

Franco Baldelli

http://www.w3.org/2001/XMLSchema#string

Vanessa Bianconi

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity

Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins

Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation

The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR

Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice

The PCSK9 decade

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

Hepatitis C virus hijacks host lipid metabolism

Hepatocyte nuclear factor 1alpha plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine

Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes

P304

3150-3161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1111/JCMM.13273

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matteo Pirro

Amirhossein Sahebkar

P577

2017-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28722331

http://www.w3.org/2001/XMLSchema#string

P921

cell surface receptor

P932

5706572

http://www.w3.org/2001/XMLSchema#string